Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1740studies shown
Showing 1,213-1,224 of 1,740
Other study type icon
Active Not RecruitingNCT07126899

Hand Tendon Injuries: An Investigation Of Attention Deficit Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Yozgat
Why is this study shown?

This study is directly about ADHD.

ADHDObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
Türkiye
Sponsor
Atılım University
Condition
ADHD
Drug study icon
Not recruitingISRCTN61683087

Examining the ora-dental health of children with ADHD

This observational study is following people with The objective of this study was to determine the ora-dental health and its relation with medication and dental fear in a group of Turkish children with ADHD, Mental and Behavioural Disorders, or Adhd to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Sudan
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 6 Years to 15 Years
Countries
Sudan, Suriname, Türkiye
Sponsor
Istanbul University
Condition
ADHD
Behavioral study icon
Not recruitingISRCTN13078441

PowerCoaching: A multiple domain CBT coaching program for adolescents with attention deficit hyperactivity disorder

This study is looking at whether Adolescents are randomized to one of two groups: Immediate treatment group: Participants receive the PowerCoaching for a total of 18 weeks can help people with Attention deficit hyperacitivty disorder and problems in daily functioning, Mental and Behavioural Disorders, or Attention deficit hyperacitivty disorder. Participants take part in Adolescents are randomized to one of two groups: Immediate treatment group: Participants receive the PowerCoaching for a total of 18 weeks and complete follow-up assessments.

In Netherlands
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 12 Years to 18 Years
Countries
Netherlands
Sponsor
Maasstad Hospital Rotterdam (Maasstadziekenhuis Rotterdam)
Condition
ADHD
Other study type icon
Not recruitingISRCTN11573246

The ADHD controversy project: Long-term effects of ADHD diagnosis

This observational study is following people with Diagnosis of ADHD or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Norway
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 5 Years to 18 Years
Countries
Norway
Sponsor
Haukeland University Hospital
Condition
ADHD
Drug study icon
Not recruitingISRCTN11891971

The ADHD controversy project: Long-term effects of ADHD medication

This observational study is following people with ADHD medication or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Norway
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 5 Years to 18 Years
Countries
Norway
Sponsor
Haukeland University Hospital
Condition
ADHD
Drug study icon
TerminatedEUCTR 2008-000191-24

An Open Label Pilot Study of Atomoxetine Hydrochloride in Adolescents with Attentioin-Deficit/Hyperactivity Disorder and Comorbid Cannabis Abuse

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about ADHD.

ADHDDrugA study involving a medication or substance.
Countries
Netherlands
Sponsor
Eli Lilly Nederland
Condition
ADHD
Drug study icon
CompletedEUCTR 2005-004037-18

An Open Label, Multicentre Study to Evaluate the Long Term Safety of Prolonged Release (PR) OROS Methylphenidate (18, 36, 54, 72 and 90 mg/day) in Adults with Attention Deficit/Hyperactivity Disor...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
Germany, Portugal, Spain
Sponsor
Janssen-Cilag Medical Affairs EMEA
Condition
ADHD
Drug study icon
TerminatedEUCTR 2020-004053-76

Effectiveness of methylphenidate in children and adults with Smith Magenis syndrome and attention-deficit/hyperactivity disorder: An N-of-1 series

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
Netherlands
Sponsor
Amsterdam UMC [...] 1. Amsterdam UMC 2. 's Heeren Loo
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.